Precision oncology via artificial intelligence on cancer biopsies

Full Article
Precision oncology via artificial intelligence on cancer biopsies

A groundbreaking AI tool named DeepHRD has been developed to enhance precision oncology by detecting genomic alterations directly from tumor biopsy slides. This innovative approach eliminates the need for costly genomic sequencing, significantly reducing both time and expenses associated with cancer treatment. The tool aims to provide equitable access to effective therapies for breast and ovarian cancer patients, addressing critical delays in treatment initiation.

The DeepHRD tool allows oncologists to prescribe treatments immediately after initial diagnosis, which is crucial for patient outcomes. With a negligible failure rate compared to traditional genomic tests, this AI-driven method promises to bridge the gap in precision medicine, especially in resource-limited settings. The collaboration among various departments at UC San Diego highlights the interdisciplinary effort to make precision oncology more accessible and efficient.

• DeepHRD tool enables rapid genomic alteration detection from biopsy slides.

• AI approach significantly reduces costs and time in cancer treatment workflows.

Key AI Terms Mentioned in this Article

Precision Oncology

The article discusses how precision oncology can be enhanced through AI tools like DeepHRD.

Genomic Alterations

DeepHRD identifies these alterations directly from biopsy slides, streamlining the treatment process.

Homologous Recombination Deficiency (HRD)

The AI tool focuses on detecting HRD to guide effective chemotherapy options.

Companies Mentioned in this Article

io9

io9 is working to bring the DeepHRD AI platform into clinical use for cancer treatment.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics